MTOR and hepatocellular carcinoma: In addition, mTOR inhibitors enhance hepatitis B virus (HBV) replication, though it is not clarified whether mTOR inhibitor suppresses hepatitis C virus (HCV) replication in patients with HCC [71, 72].